BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 27346233)

  • 1. Osteogenesis imperfecta: from diagnosis and multidisciplinary treatment to future perspectives.
    Bregou Bourgeois A; Aubry-Rozier B; Bonafé L; Laurent-Applegate L; Pioletti DP; Zambelli PY
    Swiss Med Wkly; 2016; 146():w14322. PubMed ID: 27346233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of atypical femoral fracture in a patient with osteogenesis imperfecta.
    Tan JY; Seow CJ
    BMJ Case Rep; 2017 Dec; 2017():. PubMed ID: 29269360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on the evaluation and treatment of osteogenesis imperfecta.
    Harrington J; Sochett E; Howard A
    Pediatr Clin North Am; 2014 Dec; 61(6):1243-57. PubMed ID: 25439022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Filling the gaps: osteogenesis imperfecta.
    Graul AI
    Drug News Perspect; 2005; 18(6):400-1. PubMed ID: 16247517
    [No Abstract]   [Full Text] [Related]  

  • 5. [Osteogenesis imperfecta].
    Forin V
    Presse Med; 2007 Dec; 36(12 Pt 2):1787-93. PubMed ID: 17560761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approach to the Patient: Pharmacological Therapies for Fracture Risk Reduction in Adults With Osteogenesis Imperfecta.
    Liu W; Lee B; Nagamani SCS; Nicol L; Rauch F; Rush ET; Sutton VR; Orwoll E
    J Clin Endocrinol Metab; 2023 Jun; 108(7):1787-1796. PubMed ID: 36658750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteogenesis imperfecta: diagnosis and treatment.
    Biggin A; Munns CF
    Curr Osteoporos Rep; 2014 Sep; 12(3):279-88. PubMed ID: 24964776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Osteogenesis imperfecta].
    Schuh A; Hönle W; Effenberger H
    MMW Fortschr Med; 2009 Nov; 151(48):38, 40. PubMed ID: 20085061
    [No Abstract]   [Full Text] [Related]  

  • 9. Individualized treatment with denosumab in children with osteogenesis imperfecta - follow up of a trial cohort.
    Hoyer-Kuhn H; Rehberg M; Netzer C; Schoenau E; Semler O
    Orphanet J Rare Dis; 2019 Sep; 14(1):219. PubMed ID: 31533771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TBS as a Tool to Differentiate the Impact of Antiresorptives onCortical and Trabecular Bone in Children With OsteogenesisImperfecta.
    Rehberg M; Winzenrieth R; Hoyer-Kuhn H; Duran I; Schoenau E; Semler O
    J Clin Densitom; 2019; 22(2):229-235. PubMed ID: 30309730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteogenesis imperfecta.
    Huber MA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):314-20. PubMed ID: 17223585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with bisphosphonates in osteogenesis imperfecta.
    Glorieux FH
    Pediatrics; 2007 Mar; 119 Suppl 2():S163-5. PubMed ID: 17332237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the Classification and Treatment of Osteogenesis Imperfecta.
    Thomas IH; DiMeglio LA
    Curr Osteoporos Rep; 2016 Feb; 14(1):1-9. PubMed ID: 26861807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteogenesis imperfecta, current and future medical treatment.
    Rauch F; Glorieux FH
    Am J Med Genet C Semin Med Genet; 2005 Nov; 139C(1):31-7. PubMed ID: 16278881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteogenesis imperfecta: practical treatment guidelines.
    Antoniazzi F; Mottes M; Fraschini P; Brunelli PC; Tatò L
    Paediatr Drugs; 2000; 2(6):465-88. PubMed ID: 11127846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteogenesis imperfecta: lifelong management is imperative and feasible.
    Chevrel G; Meunier PJ
    Joint Bone Spine; 2001 Mar; 68(2):125-9. PubMed ID: 11324928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Bisphosphonate Therapy in Osteogenesis Imperfecta.
    Biggin A; Munns CF
    Curr Osteoporos Rep; 2017 Oct; 15(5):412-418. PubMed ID: 28823022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous pamidronate treatment of infants with severe osteogenesis imperfecta.
    Aström E; Jorulf H; Söderhäll S
    Arch Dis Child; 2007 Apr; 92(4):332-8. PubMed ID: 17114205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of osteogenesis imperfecta in adults.
    Lindahl K; Langdahl B; Ljunggren Ö; Kindmark A
    Eur J Endocrinol; 2014 Aug; 171(2):R79-90. PubMed ID: 24760541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New trends in the treatment of osteogenesis imperfecta type III - own experience.
    Jakubowska-Pietkiewicz E; Chlebna-Sokół D
    Ortop Traumatol Rehabil; 2008; 10(6):593-601. PubMed ID: 19153548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.